Protective Effects and Mechanisms of Flavonoids in Renal Ischemia-Reperfusion Injury

Peng Peng1, Junrong Zou2,3, Bin Zhong1

  • 1The First Clinical College, Gannan Medical University, Ganzhou, China.

Pharmacology
|November 29, 2022
PubMed
Abstract

Insights

Flavonoids show promise in preventing acute kidney injury (AKI) caused by kidney surgery's ischemia/reperfusion (I/R) damage. Further research is needed to translate these findings into clinical treatments for I/R-induced AKI.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nephrology

Background:

  • Acute kidney injury (AKI) is a frequent and severe complication of kidney surgery.
  • Renal ischemia/reperfusion (I/R) injury is the primary cause of AKI in this context.
  • Effective control of I/R injury is crucial for patient outcomes.

Purpose of the Study:

  • To review the protective effects of flavonoids against renal I/R injury.
  • To explore the potential clinical applications of flavonoids in managing I/R-induced AKI.

Main Methods:

  • In vitro studies
  • Animal models
  • Literature review

Main Results:

  • Flavonoids demonstrate significant protective effects against I/R-induced AKI.
  • Mechanisms include antioxidative stress, anti-inflammation, anti-apoptosis, ER stress inhibition, and improved mitochondrial function.
  • Extensive evidence supports flavonoids' role in mitigating I/R injury.

Conclusions:

  • Flavonoids offer a promising therapeutic strategy for preventing renal I/R injury.
  • Despite demonstrated efficacy in preclinical studies, the translation of flavonoids into clinical practice for I/R-induced AKI requires further investigation.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
49
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
738
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
54
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
483
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
448